Hypertension

Macitentan/tadalafil and sotatercept approvals shifted the field, but by how much seems to differ

Clinical trials of xenotransplantation expected to kick off next year

Observational study suggests one antihypertensive class might be preventive

BPROAD trial replicates SPRINT trial findings in diabetes population in China

Diagnoses were also delayed the longer sugar was restricted

Can the fibrinogen-to-albumin ratio help with early identification?

Important to educate patients conducting home measurements, says researcher

Negative results overall hid a benefit for some who won the insurance lottery in Oregon

CDC researcher shares alarming stats and some engagement opportunities

Afib, hypertension, and others get updates with simplifications

Either choice is "acceptable" based on randomized study

Agency hopes mean intake will drop to approximately 2,750 mg/day if companies comply

Class was compared with DPP4-inhibitors

Let us handle the garden-variety hypertension and diabetes, and give them the complex cases